← Leaderboards
Andrew Greenberg
Tufts Medical Center
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Tufts Medical Center
Same institution · by research overlap
- Sherwood L Gorbach$12,233,213
- Anastassios G Pittas$52,429,112
- Francine M Foss$122,062
- Abby H Shevitz$1,805,817
- Christine A Wanke$18,324,933
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationHuman SubjectHuman Therapy EvaluationClinical ResearchHyperglycemiaHypoglycemic AgentsMetforminNoninsulin Dependent Diabetes MellitusObesityWeight Control AgentWeight LossClinical Trial Phase ICombination ChemotherapyDiabetes Mellitus Therapy
Grant awards (6)
Efficacy, safety &tolerability of BRL 996536C in NIDDM$0
M01 · FY2002 · RR
Efficacy of subcutaneous administration of A-100 in obese subjects$0
M01 · FY2002 · RR
Efficacy, safety &tolerability of BRL 996536C in NIDDM$0
M01 · FY2001 · RR
Efficacy of subcutaneous administration of A-100 in obese subjects$0
M01 · FY2001 · RR
Efficacy, safety &tolerability of BRL 996536C in NIDDM$0
M01 · FY2000 · RR
Efficacy of subcutaneous administration of A-100 in obese subjects$0
M01 · FY2000 · RR